Furthermore, in the in vivo experiments in mice, using tail vein injection of sh-USP1, the growth of tumors in mice was apparently inhibited, thereby resulting in a significantly prolonged survival period, which is of reference value for clinical researches on tumor therapies. Here, USP1 is linked to neoplasm.